Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Nelson

Showing results (111-120 of 310) with videos related to

Pageof 31
Sort By:
AIDS (London, England)|June 12, 2003
Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infectionJohn F Morlese, Chloë M Orkin, Riaz Abbas, et al.
The Medical Journal of Australia|February 23, 2021
Absolute risk assessment for guiding cardiovascular risk management in a chest pain clinicJ Andrew Black, Julie A Campbell, Serena Parker, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 10, 2025
Socioeconomic inequalities and trends in self-reported hypertension and antihypertensive medication use in Australia between 2009 and 2021: a nationwide population-based cohort studyBerhe W Sahle, Dianna J Magliano, Andre M N Renzaho, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 23, 2015
Rate of change in renal function and mortality in elderly treated hypertensive patientsEnayet K Chowdhury, Robyn G Langham, Zanfina Ademi, et al.
Journal of Immune Based Therapies and Vaccines|April 13, 2007
A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapyGareth Ad Hardy, Nesrina Imami, Mark R Nelson, et al.
Geriatrics (Basel, Switzerland)|July 25, 2023
Socio-Demographic, Lifestyle, and Clinical Characteristics of Early and Later Weight Status in Older Adults: Secondary Analysis of the ASPREE Trial and ALSOP Sub-StudyTagrid A Alharbi, Alice J Owen, Joanne Ryan, et al.
American Journal of Hypertension|November 20, 2013
Short- and long-term survival in treated elderly hypertensive patients with or without diabetes: findings from the Second Australian National Blood Pressure studyEnayet K Chowdhury, Alice Owen, Zanfina Ademi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2014
Five-year safety evaluation of maraviroc in HIV-1-infected treatment-experienced patientsRoy M Gulick, Gerd Fatkenheuer, Robert Burnside, et al.
The American Journal of Cardiology|August 16, 2018
Relation of Alcohol Consumption to Risk of Heart Failure in Patients Aged 65 to 84 Years With HypertensionBerhe W Sahle, Alice J Owen, Lindon M H Wing, et al.
AIDS (London, England)|September 15, 2004
Atazanavir enhances saquinavir hard-gel concentrations in a ritonavir-boosted once-daily regimenMarta Boffito, Michael Kurowski, Guido Kruse, et al.
Pageof 31

Showing results (111-120 of 310) with videos related to

Sort By:
Pageof 31
AIDS (London, England)|June 12, 2003
Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infectionJohn F Morlese, Chloë M Orkin, Riaz Abbas, et al.
The Medical Journal of Australia|February 23, 2021
Absolute risk assessment for guiding cardiovascular risk management in a chest pain clinicJ Andrew Black, Julie A Campbell, Serena Parker, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 10, 2025
Socioeconomic inequalities and trends in self-reported hypertension and antihypertensive medication use in Australia between 2009 and 2021: a nationwide population-based cohort studyBerhe W Sahle, Dianna J Magliano, Andre M N Renzaho, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 23, 2015
Rate of change in renal function and mortality in elderly treated hypertensive patientsEnayet K Chowdhury, Robyn G Langham, Zanfina Ademi, et al.
Journal of Immune Based Therapies and Vaccines|April 13, 2007
A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapyGareth Ad Hardy, Nesrina Imami, Mark R Nelson, et al.
Geriatrics (Basel, Switzerland)|July 25, 2023
Socio-Demographic, Lifestyle, and Clinical Characteristics of Early and Later Weight Status in Older Adults: Secondary Analysis of the ASPREE Trial and ALSOP Sub-StudyTagrid A Alharbi, Alice J Owen, Joanne Ryan, et al.
American Journal of Hypertension|November 20, 2013
Short- and long-term survival in treated elderly hypertensive patients with or without diabetes: findings from the Second Australian National Blood Pressure studyEnayet K Chowdhury, Alice Owen, Zanfina Ademi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2014
Five-year safety evaluation of maraviroc in HIV-1-infected treatment-experienced patientsRoy M Gulick, Gerd Fatkenheuer, Robert Burnside, et al.
The American Journal of Cardiology|August 16, 2018
Relation of Alcohol Consumption to Risk of Heart Failure in Patients Aged 65 to 84 Years With HypertensionBerhe W Sahle, Alice J Owen, Lindon M H Wing, et al.
AIDS (London, England)|September 15, 2004
Atazanavir enhances saquinavir hard-gel concentrations in a ritonavir-boosted once-daily regimenMarta Boffito, Michael Kurowski, Guido Kruse, et al.
Pageof 31